Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1508 of 6351
-
New RSV drug trial aims to protect vulnerable adults
Disease control Recruiting nowThe main purpose of this study is to investigate the antiviral effect of S-337395 compared with placebo among nonhospitalized adult participants with high-risk factors for progression to severe RSV infection starting intervention within 72 hours of RSV symptom onset.
Phase 2 • Sponsor: Shionogi • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New Balloon-Based ablation device tested in Real-World AFib patients
Disease control Recruiting nowThis study is designed to obtain real-world clinical evidence on the safety and effectiveness of the Volt PFA System in various use cases, with a sub study designed to address additional clinical evidence needs in electrophysiology.
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Shorter radiation course for sarcoma shows promise in new trial
Disease control Recruiting nowBased upon the preliminary data derived from first SCOPES clinical trial and the results of patients treated during the recent COVID-19 pandemic, patients with soft tissue sarcomas (STS) can be preoperatively irradiated in a modestly hypofractionated schedule of 14 x 3 Gy. From a…
Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug shows promise for managing short bowel syndrome Long-Term
Disease control OngoingThe purpose of this study is to understand the safety and efficacy of twice weekly glepaglutide 10 mg in adult patients with short bowel syndrome (SBS), who were previously enrolled in the EASE SBS 2 or EASE SBS 3 trials. Participants currently on these trials will be able to con…
Phase 3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Electric pulses could replace surgery for some breast cancers
Disease control Recruiting nowThis is a prospective, open-label, single-arm, exploratory clinical trial conducted at our institution to investigate the use of Irreversible Electroporation (IRE) for the treatment of breast cancer.
Sponsor: Tian'an Jiang • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New smart pump system tested for better diabetes control in real life
Disease control Recruiting nowThis is a non-interventional, longitudinal, prospective, multicenter, post market-registration and national study conducted in France. The study is conducted among participants with type 1 diabetes (T1D) using the mylife CamAPS FX hybrid closed-loop insulin delivery system combin…
Sponsor: mylife Diabetes Care AG • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Stem Cell-Derived 'Living Drug' takes aim at tough autoimmune conditions
Disease control Not yet recruitingThis study primarily involves the use of BCT301, an anti-CD19 Chemically induced pluripotent stem cell (CiPSC)-derived CAR-iT cells, for the treatment of patients with refractory autoimmune diseases, aiming to evaluate its safety, tolerability, and dose-limiting toxicities(DLT), …
Early phase 1 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New PET scan could slash radiation exposure for tumor patients
Diagnosis Recruiting nowThe goal of this clinical trial is to evaluate an investigational ultralow dose positron emission tomography (PET) imaging technique for neuroendocrine tumor detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duratio…
Phase 2 • Sponsor: Akiva Mintz • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
New drug ST-001 tested in lung cancer patients who have run out of options
Disease control Recruiting nowThis study evaluates a fenretinide phospholipid suspension for the treatment of small cell lung cancer (SCLC).
Phase 1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Prune power: could 5 prunes a day save your bones?
Prevention Recruiting nowDietary interventions of prune consumption during the transmenopausal period are innovative methods to prevent bone loss. Modern medicine does not intervene to prevent or attenuate this highly vulnerable period of bone loss which, if successfully attenuated, can potentially preve…
Sponsor: Penn State University • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
Can acupuncture and exercise ease pelvic pain during pregnancy?
Symptom relief CompletedStudy's Objective: this study aimed to discover the effect of combining electroacupuncture with therapeutic exercises on of symphysis pubis dysfunction during pregnancy.A prospective randomized controlled trial that compared 2 groups of participants was executed. 60 primipara and…
Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Arm cuff may stop stroke from worsening
Disease control Recruiting nowThis study aims to conduct a prospective, randomized, double-blind, multicenter, parallel-controlled, group-sequential trialto scientifically evaluate the safety and efficacy of remote ischemic preconditioning (RIC) in preventing early neurological deterioration (END) in patients…
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New Botox-Like shot could loosen stiff arms in stroke survivors
Symptom relief Recruiting nowThis is a phase III clinical study to evaluate the efficacy and safety of recombinant botulinum toxin type A(Eveotox)in adult patients with upper limb spasticity. The purpose of this study was to observe efficacy and safety of Eveotox compared with placebo in adult patients with …
Phase 3 • Sponsor: JHM BioPharma (Tonghua) Co. , Ltd. • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
No knife needed? new procedure may treat appendicitis without surgery
Disease control Recruiting nowThis study compares two ways of treating acute uncomplicated appendicitis, which is a mild form of appendicitis. In the Direct Visualization ERAT group, participants will receive Endoscopic Retrograde Appendicitis Therapy (ERAT). This is a minimally invasive, non-surgical treatme…
Sponsor: Changhai Hospital • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Smart sensors and AI aim to spot pregnancy diabetes sooner
Knowledge-focused Not yet recruitingGestational diabetes mellitus (GDM), as the most common metabolic complication of pregnancy, poses a serious threat to maternal and fetal metabolic health. However, current GDM diagnosis faces several problems such as static, single-point, cumbersome to operate and delayed diagno…
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Can a new pill tame immunotherapy's worst side effects and let patients restart treatment?
Disease control Not yet recruitingThis study is a Phase II, two-cohort, multicenter, two-stage clinical trial. It plans to enroll 72 subjects with solid tumors who discontinued prior ICI therapy due to irAE. Cohort 1 enrolls subjects with irAE resistant to or dependent on corticosteroid therapy. Subjects in Cohor…
Phase 2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New hope for tough anemia: daratumumab trial launches
Disease control Not yet recruitingThis study consists of two phases, phase Ib and phase II. The primary objective of phase Ib is to evaluate the safety and tolerability of multiple doses of daratumumab in patients with refractory aplastic anemia. The primary objective of phase II is to preliminarily assess the ef…
Phase 1/2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Radioactive injection targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study is an open, multicenter, dose-escalation and cohort-expansion non-randomized phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of Lutetium \[177Lu\] BL-ARC001 in patients with locally advanced or metas…
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New combo therapy shows promise for tough bile duct cancer
Disease control Recruiting nowThis prospective real-world study aims to evaluate the effectiveness and safety of an alternating treatment regimen combining hepatic arterial infusion chemotherapy (HAIC) with systemic chemotherapy, with or without adebrelimab and apatinib, in patients with unresectable biliary …
Phase 2 • Sponsor: Air Force Military Medical University, China • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
MRI as a detective for hip pain: a new study puts it to the test
Diagnosis OngoingTo evaluate the role of Magnetic Resonance Imaging in the assessment and diagnosis of patients presenting with hip pain.
Sponsor: Sohag University • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC